[CGH (comparative genomic hybridization)]. 1996

M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
Department of Gynecology, Sasaki Institute Kyoundo Hospital.

Comparative Genomic Hybridization (CGH) is a powerful new method which allows genome-wide mapping of regions with DNA sequence copy number changes (both increases and decreases) in a single experiment without previous knowledge of the locations of the regions of abnormality. CGH is based on in situ hybridization of differentially labeled total genomic tumor DNA and normal DNA to normal human metaphase chromosomes. After hybridization copy number variations among the sequences in the tumor DNA are detected by measuring the tumor/normal fluorescence intensity ratio for each locus in the target chromosomes. Many previously unknown chromosomal regions with relative copy number changes have been detected in various tumors by CGH. Some changes have been identified as genetic markers associated with biological and clinico-pathological characteristics (i.e., histopathological grade, and clinical outcome). We review the published CGH articles and discuss briefly on current progress in CGH analysis to ovarian and uterine cervical cancer in our laboratory.

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm
D015894 Genome, Human The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs. Human Genome,Genomes, Human,Human Genomes
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
September 1993, Human cell,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 2013, Methods in molecular biology (Clifton, N.J.),
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 2019, Methods in molecular biology (Clifton, N.J.),
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
June 2007, International journal of urology : official journal of the Japanese Urological Association,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
April 2003, Genome,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 2010, Methods in molecular biology (Clifton, N.J.),
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 1993, Journal of cellular biochemistry. Supplement,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 2004, Frontiers in bioscience : a journal and virtual library,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
February 2015, Journal of visualized experiments : JoVE,
M Sakamoto, and H Sakamoto, and Y Suehiro, and T Akiya, and H Iwabuchi, and H Sakunaga, and T Muroya, and T Noda, and T Sugishita, and Y Tenjin
January 1999, Annales de pathologie,
Copied contents to your clipboard!